NADPH oxidase inhibitor apocynin prevents atrial remodeling in alloxan-induced diabetic rabbits
Jiuchun Qiu(Second Hospital of Tianjin Medical University), Guangping Li(Qingdao University), Yajuan Yang(Second Hospital of Tianjin Medical University), Zhiwei Zhang(Second Hospital of Tianjin Medical University), Xiaowei Zhang(Lanzhou University Second Hospital), Xue Liang(Chongqing Normal University), Tong Liu(Second Hospital of Tianjin Medical University), Jian Li(Huadong Hospital), Panagiotis Korantzopoulos(University of Ioannina), Huaying Fu(Second Hospital of Tianjin Medical University), Jianping Zhao(Xinjiang University)
Cited by 27
Related Papers
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
|The Lancet|2020|51.8k
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
|The Lancet|2020|3.7k
Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan
|Journal of Allergy and Clinical Immunology|2020|2.4k
Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study
|The Lancet|2018|1.7k
Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study
|Chinese Medical Journal|2020|1.4k